S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:SAGE

Sage Therapeutics SEC Filings & 10K Form

$85.00
+1.55 (+1.86 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$80.47
Now: $85.00
$85.15
50-Day Range
$78.47
MA: $85.62
$96.76
52-Week Range
$25.01
Now: $85.00
$98.39
Volume1.07 million shs
Average Volume502,165 shs
Market Capitalization$4.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.23

SEC Filings

Sage Therapeutics (NASDAQ:SAGE) SEC Filings

DateFilerForm TypeView
02/24/2021
6:46 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2021
6:15 AM
Sage Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2021
5:46 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
9:14 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
01/28/2021
3:02 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
3:06 PM
Sage Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/11/2021
3:30 PM
BIOGEN INC. (Reporting)
Biogen MA Inc. (Reporting)
Sage Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2021
3:19 PM
BIOGEN INC. (Filed by)
Sage Therapeutics (Subject)
Form SC 13G
01/08/2021
3:37 PM
BlackRock Inc. (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
01/07/2021
3:14 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
3:05 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
6:00 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2020
6:38 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
6:15 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:00 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2020
8:14 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
3:43 PM
Greene Barry E (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
3:41 PM
Greene Barry E (Reporting)
Sage Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
3:05 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
6:20 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
6:00 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
1:32 PM
Sage Therapeutics (Filer)
Form CT ORDER
05/07/2020
3:27 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2020
3:58 PM
Cloonan Michael (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2020
3:53 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2020
6:32 AM
Sage Therapeutics (Filer)
Form DEFA14A
04/29/2020
6:30 AM
Sage Therapeutics (Filer)
Form DEF 14A
04/13/2020
12:47 PM
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
04/07/2020
3:25 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
5:57 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2020
6:32 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2020
6:17 AM
Sage Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
3:57 PM
Kanes Stephen (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:57 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:57 PM
Cook Anne Marie (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
9:33 AM
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
01/07/2020
3:53 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
8:26 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
7:04 PM
Robichaud Albert (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
7:04 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
6:01 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
6:16 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
5:44 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
4:00 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:33 PM
Kanes Stephen (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:04 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
6:16 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:04 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
7:00 PM
Cloonan Michael (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
7:00 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
7:00 PM
Robichaud Albert (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
6:59 PM
Kanes Stephen (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
6:59 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
6:58 PM
Cook Anne Marie (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2019
5:02 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
6:18 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:02 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
3:01 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:18 PM
Kanes Stephen (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:18 PM
Robichaud Albert (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:17 PM
Cook Anne Marie (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:16 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:16 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
8:03 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
3:36 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
3:02 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM
Nayak Asha (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM
Germano Geno J (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM
COLA MICHAEL F (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM
Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM
Sage Therapeutics (Issuer)
STARR KEVIN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
3:01 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
5:24 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
3:00 PM
Cloonan Michael (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:31 PM
Cook Anne Marie (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
5:21 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:25 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
6:16 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:04 PM
Sage Therapeutics (Filer)
Form DEFA14A
04/25/2019
3:01 PM
Sage Therapeutics (Filer)
Form DEF 14A
03/22/2019
3:22 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
7:47 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
8:08 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
4:03 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
4:48 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:05 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
7:08 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
7:04 AM
Sage Therapeutics (Filer)
Form 424B5
02/25/2019
3:07 PM
Sage Therapeutics (Filer)
Form 424B5
02/20/2019
6:55 AM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:50 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/19/2019
6:33 AM
Sage Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2019
6:07 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
3:31 PM
Cook Anne Marie (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
3:31 PM
Cloonan Michael (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
3:30 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
7:30 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.